Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL Research Letter
| Authors: | Kittai, A. S.; Huang, Y.; Miller, S.; Allan, J. N.; Bhat, S. A.; Bond, D. A.; Brander, D. M.; Byrd, J. C.; Chavez, J. C.; Chong, E.; Davids, M. S.; Danilov, A. V.; Ding, W.; Dowling, M. R.; Dvorak-Kornaus, K.; Freedman, H.; Hampel, P. J.; Ho, C.; Hwang, S. R.; Islam, P.; Malakhov, N.; Matasar, M.; Miller, C.; Omer, Z.; Parikh, S. A.; Parry, E.; Rabe, K. G.; Raess, P. W.; Rai, M.; Roeker, L.; Rhodes, J.; Rogers, K. A.; Saha, A.; Schade, J.; Scott, H. W.; Shadman, M.; Shouse, G.; Skarbnik, A.; Spurgeon, S.; Stephens, D. M.; Thompson, M. C.; Thompson, P. A.; Wang, Y.; Yano, M.; Woyach, J. A. |
| Title: | Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL |
| Keywords: | adult; cancer survival; controlled study; treatment outcome; treatment response; aged; survival rate; major clinical study; overall survival; allogeneic stem cell transplantation; cancer patient; follow up; antineoplastic agent; letter; progression free survival; cohort analysis; lactate dehydrogenase; chronic lymphatic leukemia; karyotype; chemoradiotherapy; standardized uptake value; molecularly targeted therapy; survival prediction; diffuse large b cell lymphoma; chemoimmunotherapy; richter syndrome; human; male; female; median survival time; positron emission tomography-computed tomography; chimeric antigen receptor t-cell immunotherapy; cell therapy agent |
| Journal Title: | Blood Cancer Journal |
| Volume: | 15 |
| ISSN: | 2044-5385 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2025-02-20 |
| Start Page: | 23 |
| Language: | English |
| DOI: | 10.1038/s41408-025-01236-6 |
| PUBMED: | 39979241 |
| PROVIDER: | scopus |
| PMCID: | PMC11842760 |
| DOI/URL: | |
| Notes: | Letter -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
